Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats

Responses to drugs affecting 5-hydroxytryptamine (5-HT) and dopaminergic (DA) system have been examined in rats after repeated immobilization. Groups of rats were immobilized for 2 h per day for up to 7 days. Twenty-four hours later their behavioural responses to various drugs were tested. Rats immobilized for 7 days showed decreased sniffing and increased grooming and body shakes. When given amphetamine (3 mg/kg, i.p.) the intensity of classical dopamine-dependent behaviours was similar to that of non-immobilized controls. Some responses to the 5-HT releaser p-chloroamphetamine (PCA) (4 and 10 mg/kg, i.p.) and the 5-HT agonist 5-methoxy-N,N-dimethyltryptamine (5-MEODMT) (5 mg/kg, i.p.) (forepaw treading and tremor) were enhanced after 7 days immobilization but others (limb abduction and headweaving) were not. These responses were not enhanced after 1 or 3 days immobilization. Backward walking and body shakes induced by PCA were also enhanced after 7 days immobilization. Concentrations of 5-HT, DA and their metabolites in striatum, cortex, hippocampus, hypothalamus and midbrain of non-drug-treated control and immobilized groups were comparable. Brain PCA concentrations 30 min after injection were also comparable. The above biochemical and behavioural data suggest that repeated immobilization increases some 5-HT postsynaptic functions. These results are discussed in relation to non-drug-provoked behavioural abnormalities occurring 24 h after the first immobilization but no longer evident after 7 periods of immobilization.

[1]  D. Grahame-Smith,et al.  Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by l‐tryptophan or 5‐methoxy‐N,N‐dimethyltryptamine in rats treated with a monoamine oxidase inhibitor , 1971, British journal of pharmacology.

[2]  E. Azmitia,et al.  Selective destruction of the serotonergic fibers of the fornix-fimbria and cingulum bundle increases 5-HT1 but not 5-HT2 receptors in rat midbrain. , 1983, European journal of pharmacology.

[3]  C. Dourish A PHARMACOLOGICAL ANALYSIS OF THE HYPERACTIVITY SYNDROME INDUCED BY β‐PHENYLETHYLAMINE IN THE MOUSE , 1982, British journal of pharmacology.

[4]  H. Praag Depression, suicide and the metabolism of serotonin in the brain ☆ , 1982 .

[5]  C. D. Andrews,et al.  Differential involvement of dopamine-containing tracts in 5-hydroxytryptamine-dependent behaviours caused by amphetamine in large doses , 1982, Neuropharmacology.

[6]  K. Fuxe,et al.  Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons. , 1972, European journal of pharmacology.

[7]  F. Hirata,et al.  Mepacrine treatment prevents immobilization-induced desensitization of beta-adrenergic receptors in rat hypothalamus and brain stem , 1981, Brain Research.

[8]  A. Lees,et al.  BACKWARD WALKING AND CIRCLING: BEHAVIOURAL RESPONSES INDUCED BY DRUG TREATMENTS WHICH CAUSE SIMULTANEOUS RELEASE OF CATECHOLAMINES AND 5‐HYDROXYTRYPTAMINE , 1979, British journal of pharmacology.

[9]  T. Harris,et al.  Life events and psychiatric disorders Part 2: nature of causal link , 1973, Psychological Medicine.

[10]  B. Jacobs,et al.  Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine. , 1976, European journal of pharmacology.

[11]  J. Leysen,et al.  [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. , 1982, Molecular pharmacology.

[12]  E L Bliss,et al.  Relationship of stress and activity to brain dopamine and homovanillic acid. , 1971, Life sciences. Pt. 1: Physiology and pharmacology.

[13]  M. H. Joseph,et al.  Stress-induced release of 5-HT in the hippocampus and its dependence on increased tryptophan availability: an in vivo electrochemical study , 1983, Brain Research.

[14]  J. Hall,et al.  A BEHAVIOURAL AND BIOCHEMICAL STUDY IN RATS OF 5‐HYDROXYTRYPTAMINE RECEPTOR AGONISTS AND ANTAGONISTS, WITH OBSERVATIONS ON STRUCTURE‐ACTIVITY REQUIREMENTS FOR THE AGONISTS , 1981, British journal of pharmacology.

[15]  J. Weiss Effects of coping responses on stress. , 1968, Journal of comparative and physiological psychology.

[16]  G. Curzon,et al.  Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour , 1983, Neuropharmacology.

[17]  R. Kvetňanský,et al.  CATECHOLAMINES AND CORTICOSTEROIDS IN ACUTE AND REPEATED STRESS , 1976 .

[18]  R. Rose,et al.  The relation of psychological stress to onset of medical illness. , 1976, Annual review of medicine.

[19]  B. Carroll,et al.  Acute and chronic stress effects on open field activity in the rat: Implications for a model of depression , 1981, Neuroscience & Biobehavioral Reviews.

[20]  B. Jacobs,et al.  An animal behavior model for studying central serotonergic synapses. , 1976, Life sciences.

[21]  E. Bliss,et al.  Response of neurogenic amines to aggregation and strangers. , 1969, The Journal of pharmacology and experimental therapeutics.

[22]  M. Palkovits,et al.  Effect of stress on serotonin concentration and tryptophan hydroxylase activity of brain nuclei. , 1976, Neuroendocrinology.

[23]  D. Grahame-Smith STUDIES IN VIVO ON THE RELATIONSHIP BETWEEN BRAIN TRYPTOPHAN, BRAIN 5‐HT SYNTHESIS AND HYPERACTIVITY IN RATS TREATED WITH A MONOAMINE OXIDASE INHIBITOR AND L‐TRYPTOPHAN , 1971, Journal of neurochemistry.

[24]  M. Seligman,et al.  Failure to escape traumatic shock. , 1967, Journal of experimental psychology.

[25]  S H Snyder,et al.  Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. , 1979, Molecular pharmacology.

[26]  D. Cooke,et al.  The Aetiological Importance of Stressful Life Events , 1983, British Journal of Psychiatry.

[27]  J. Deakin,et al.  THE EFFECTS OF PUTATIVE 5‐HYDROXYTRYPTAMINE ANTAGONISTS ON THE BEHAVIOUR PRODUCED BY ADMINISTRATION OF TRANYLCYPROMINE AND L‐TRYPTOPHAN OR TRANYLCYPROMINE AND L‐DOPA TO RATS , 1978, British journal of pharmacology.

[28]  E. Stone Reduction by stress of norepinephrine‐stimulated accumulation of cyclic AMP in rat cerebral cortex , 1979, Journal of neurochemistry.

[29]  C. D. Andrews,et al.  The effects of lesions produced by 5,7-dihydroxytryptamine on 5-hydroxytryptamine-mediated behaviour induced by amphetamine in large doses in the rat , 1984, Neuropharmacology.

[30]  M. H. Joseph,et al.  EFFECTS OF IMMOBILIZATION AND FOOD DEPRIVATION ON RAT BRAIN TRYPTOPHAN METABOLISM , 1972, Journal of neurochemistry.

[31]  G. Curzon,et al.  Effects of hydrocortisone and immobilization on tryptophan metabolism in brain and liver of rats of different ages. , 1975, Biochemical pharmacology.

[32]  J. Weiss,et al.  Behavioral depression produced by an uncontrollable stressor: Relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain , 1981, Brain Research Reviews.

[33]  K. O'Shaughnessy,et al.  Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone , 1983, Neuropharmacology.

[34]  M. Åsberg,et al.  "Serotonin depression"--a biochemical subgroup within the affective disorders? , 2003, Science.

[35]  J. Weiss,et al.  Effects of Acute Exposure to Stressors on Subsequent Avoidance‐Escape Behavior* , 1975, Psychosomatic medicine.

[36]  N. Hirschhorn Letter: Single solution for oral therapy of diarrhoea. , 1975, Lancet.

[37]  B. Jacobs,et al.  Brain stem and spinal cord mediation of a serotonergic behavioral syndrome , 1975, Brain Research.

[38]  F. G. Henke,et al.  Mental diagnosis by the association reaction method , 1909 .

[39]  R. S. Sloviter,et al.  Specificity of a rat behavioral model for serotonin receptor activation. , 1978, The Journal of pharmacology and experimental therapeutics.

[40]  J. Bartlett,et al.  SUBSTANCES RELATED TO 5‐HYDROXYTRYPTAMINE IN PLASMA AND IN LUMBAR AND VENTRICULAR FLUIDS OF PSYCHIATRIC PATIENTS , 1980, Acta psychiatrica Scandinavica.

[41]  D. Middlemiss,et al.  8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. , 1983, European journal of pharmacology.

[42]  M. H. Joseph,et al.  Does in vivo voltammetry in the hippocampus measure 5-HT release? , 1982, Brain Research.

[43]  A. Herbet,et al.  Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. , 1978, Molecular pharmacology.

[44]  J. Axelrod Studies on sympathomimetic amines. II. The biotransformation and physiological disposition of d-amphetamine, d-p-hydroxyamphetamine and d-methamphetamine. , 1954, The Journal of pharmacology and experimental therapeutics.

[45]  W. Weiner,et al.  Modification of central serotonergic and dopaminergic behaviors in the course of chronic corticosteroid administration. , 1982, European journal of pharmacology.

[46]  J. R. Hodges,et al.  The effect of injected corticosterone on the release of adrenocorticotrophic hormone in rats exposed to acute stress , 1963, The Journal of physiology.

[47]  S. Antelman,et al.  Interchangeability of stress and amphetamine in sensitization. , 1980, Science.

[48]  C. Pycock,et al.  ‘Wet-Dog’ shake behaviour in the rat: A possible quantitative model of central 5-hydroxytryptamine activity , 1977, Neuropharmacology.

[49]  H. Yamamura,et al.  Discrimination of Multiple [3H]5‐Hydroxytryptamine Binding Sites by the Neuroleptic Spiperone in Rat Brain , 1981, Journal of neurochemistry.

[50]  E. Paykel,et al.  Contribution of life events to causation of psychiatric illness , 1978, Psychological Medicine.

[51]  J. E. Platt,et al.  Brain Adrenergic receptors and resistance to stress , 1982, Brain Research.

[52]  G. Curzon,et al.  Behavioural responses to drugs releasing 5-hydroxytryptamine and catecholamines: Effects of treatments altering precursor concentrations in brain , 1981, Neuropharmacology.

[53]  M. H. Joseph,et al.  The functional importance of increased brain tryptophan in the serotonergic response to restraint stress , 1981, Neuropharmacology.

[54]  S. Nomura,et al.  Stress and β-adrenergic receptor binding in the rat's brain , 1981, Brain Research.

[55]  J. B. Stanton,et al.  5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. , 1966, Lancet.

[56]  C. Marsden,et al.  The role of tryptamine in the behavioural effects of tranylcypromine + l-tryptophan , 1979, Neuropharmacology.